| Production of a new tissue-engineered adipose substitute from human adipose-derived stromal cells M Vermette, V Trottier, V Ménard, L Saint-Pierre, A Roy, J Fradette Biomaterials 28 (18), 2850-2860, 2007 | 248 | 2007 |
| UGT genomic diversity: beyond gene duplication C Guillemette, E Lévesque, M Harvey, J Bellemare, V Menard Drug metabolism reviews 42 (1), 24-44, 2010 | 186 | 2010 |
| Circulating estrogens in endometrial cancer cases and their relationship with tissular expression of key estrogen biosynthesis and metabolic pathways J Lépine, E Audet-Walsh, J Gregoire, B Têtu, M Plante, V Ménard, ... The Journal of Clinical Endocrinology & Metabolism 95 (6), 2689-2698, 2010 | 91 | 2010 |
| Worldwide variation in human drug-metabolism enzyme genes CYP2B6 and UGT2B7: implications for HIV/AIDS treatment J Li, V Menard, RL Benish, RJ Jurevic, C Guillemette, M Stoneking, ... Pharmacogenomics 13 (5), 555-570, 2012 | 89 | 2012 |
| Copy‐number variations (CNVs) of the human sex steroid metabolizing genes UGT2B17 and UGT2B28 and their associations with a UGT2B15 functional … V Ménard, O Eap, M Harvey, C Guillemette, É Lévesque Human mutation 30 (9), 1310-1319, 2009 | 71 | 2009 |
| A pharmacogenomics study of the human estrogen glucuronosyltransferase UGT1A3 B Caillier, J Lépine, J Tojcic, V Ménard, L Perusse, A Bélanger, O Barbier, ... Pharmacogenetics and genomics 17 (7), 481-495, 2007 | 52 | 2007 |
| Transcriptional diversity at the UGT2B7 locus is dictated by extensive pre-mRNA splicing mechanisms that give rise to multiple mRNA splice variants V Ménard, O Eap, J Roberge, M Harvey, E Lévesque, C Guillemette Pharmacogenetics and genomics 21 (10), 631-641, 2011 | 38 | 2011 |
| Extensive splicing of transcripts encoding the bile acid-conjugating enzyme UGT2B4 modulates glucuronidation E Lévesque, V Ménard, I Laverdière, J Bellemare, O Barbier, H Girard, ... Pharmacogenetics and genomics 20 (3), 195-210, 2010 | 36 | 2010 |
| Analysis of inherited genetic variations at the UGT1 locus in the French‐Canadian population V Ménard, H Girard, M Harvey, L Pérusse, C Guillemette Human mutation 30 (4), 677-687, 2009 | 36 | 2009 |
| Modulation of the UGT2B7 enzyme activity by C-terminally truncated proteins derived from alternative splicing V Ménard, P Collin, G Margaillan, C Guillemette Drug Metabolism and Disposition 41 (12), 2197-2205, 2013 | 28 | 2013 |
| Expression of UGT2B7 is driven by two mutually exclusive promoters and alternative splicing in human tissues: changes from prenatal life to adulthood and in kidney cancer V Ménard, E Lévesque, S Chen, O Eap, MS Joy, L Ekström, A Rane, ... Pharmacogenetics and genomics 23 (12), 684-696, 2013 | 23 | 2013 |
| USING TARGETED QUANTITATIVE PROTEOMICS TO BETTER UNDERSTAND VARIABILITY OF THE GLUCURONIDATION PATHWAY G Margaillan, K Klein, V Menard, L Villeneuve, JK Fallon, P Caron, ... DRUG METABOLISM REVIEWS 45, 64-64, 2014 | | 2014 |
| Étude de l'épissage alternatif des UGT2B V Ménard Université Laval, 2013 | | 2013 |
| Transcriptional diversity at the UGT2B7 locus is dictated by extensive pre-mRNA splicing V Menard, O Eap, J Roberge, M Harvey, E Levesque, C Guillemette DRUG METABOLISM REVIEWS 43, 57-57, 2011 | | 2011 |
| UGT genomic diversity: beyond gene duplication É Lévesque, J Bellemare, M Harvey, V Ménard, C Guillemette Informa Healthcare, 2009 | | 2009 |
| Étude pharmacogénomique du gène UGT1 dans la population canadienne-française V Ménard Université Laval, 2008 | | 2008 |
| Expression profiling of estrogen and androgen metabolizing UGTs in uterine adenocarcinoma cancers. J Lepine, V Menard, M Plante, B Tetu, J Gregoire, L Villeneuve, ... Cancer Research 67 (9_Supplement), 4296-4296, 2007 | | 2007 |
| Grobbee DE Grond-Ginsbach C Grover S Guadagni F Guchelaar H P Abete, D Alexopoulos, D Aradi, TM Baye, RC Becker, RL Benish, J Borg, ... | | |
